Retatrutide — lab test, May 2026
COA KVR-2026-1D4A0C matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
MM5BGYRTest results
About this test
Label 30 mg · Lab measured 34.28 mg
114% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 8.6 mg using the measured mass, against 7.5 mg on the label — 14% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | KVR-2026-1D4A0C |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 14 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Retatrutide, performed by Kovera Labs on May 2, 2026. Reported purity: 99.41%. Net content: 34.28 mg against 30 mg labeled (114% of label). Tested content exceeds the labeled amount by 14%. Endotoxins: PASS (≤0.5 EU/mL). Heavy metals: As, Cd, Pb, Hg — all Negative. Batch SP26-RETA30-03. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion